Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Heads's Profile
Displaying 251-300 of 379 result(s).
CYDY CytoDyn Inc
04/27/2020 2:09:43 PM
The last question about politics an (6)
CYDY CytoDyn Inc
04/27/2020 9:18:12 AM
"Shorts" hate 9:15 am PRs!!!! (3)
CYDY CytoDyn Inc
04/27/2020 9:13:26 AM
BLA filed!!!! (2)
CYDY CytoDyn Inc
04/27/2020 7:37:48 AM
Just reported this morning that Reg (2)
CYDY CytoDyn Inc
04/26/2020 7:21:23 PM
That's great news Sunny. BTW, Jerem
CYDY CytoDyn Inc
04/26/2020 8:22:07 AM
And there was another television pi (1)
CYDY CytoDyn Inc
04/25/2020 10:24:29 PM
And the reporter says at the end of
CYDY CytoDyn Inc
04/25/2020 10:18:24 PM
A nice little television piece from
CYDY CytoDyn Inc
04/25/2020 9:14:08 AM
There has to be a reason why the CC (1)
CYDY CytoDyn Inc
04/24/2020 12:27:40 PM
Meso sounds good. But it requires i
CYDY CytoDyn Inc
04/24/2020 7:34:59 AM
Contrary to what has been said by s (1)
CYDY CytoDyn Inc
04/22/2020 3:49:33 PM
You may have missed my post CDiddy (1)
CYDY CytoDyn Inc
04/22/2020 3:33:33 PM
Fellow longs: Thursday April 23 is (5)
CYDY CytoDyn Inc
04/21/2020 10:45:58 PM
Great find Thrifty, I am not surpri (1)
CYDY CytoDyn Inc
04/21/2020 7:32:23 PM
Actually, upon further thought, NP'
CYDY CytoDyn Inc
04/21/2020 7:26:37 PM
At last week's Next Super Stock tal
CYDY CytoDyn Inc
04/20/2020 9:49:49 PM
Having now seen it, I agree that th
CYDY CytoDyn Inc
04/20/2020 8:26:40 PM
Great, but let's not fill up the 50 (2)
CYDY CytoDyn Inc
04/16/2020 9:26:38 AM
Oh, I did not know that. Thanks for
CYDY CytoDyn Inc
04/16/2020 8:04:39 AM
I think tomorrow's CC is in additio (1)
CYDY CytoDyn Inc
04/16/2020 7:52:25 AM
I've said it before, and I'll say i (2)
CYDY CytoDyn Inc
04/15/2020 11:34:23 PM
Regarding the Humanigen phase 3 tri
CYDY CytoDyn Inc
04/15/2020 5:38:03 PM
Numbr1, see my last post about Vand (1)
CYDY CytoDyn Inc
04/15/2020 5:22:48 PM
HCIT, this Vanda trial being covere (1)
CYDY CytoDyn Inc
04/15/2020 7:41:35 AM
Well said TechGuru. I would only ad (2)
CYDY CytoDyn Inc
04/13/2020 7:09:22 PM
I see that the prevailing view on I
CYDY CytoDyn Inc
04/13/2020 3:54:46 PM
Blafarm, I respectfully disagree wi
CYDY CytoDyn Inc
04/13/2020 3:32:35 PM
I still believe that although full (1)
CYDY CytoDyn Inc
04/12/2020 4:07:44 PM
Thanks for the link Sunny. Fellow l (3)
CYDY CytoDyn Inc
04/11/2020 10:20:58 PM
Ok, now I am officially frustrated!
CYDY CytoDyn Inc
04/11/2020 12:46:22 PM
Jbeck, thanks for posting. Newsweek (1)
CYDY CytoDyn Inc
04/11/2020 11:19:52 AM
I have been curious why Novant Heal (1)
CYDY CytoDyn Inc
04/10/2020 8:47:13 PM
Triage, you are so right; this migh
CYDY CytoDyn Inc
04/10/2020 8:44:57 PM
Thrifty, thank you so much for brin (1)
CYDY CytoDyn Inc
04/10/2020 11:29:03 AM
I know that NP is hoping to get a g
CYDY CytoDyn Inc
04/09/2020 10:42:06 PM
I just heard that Dr. Fauci will be
CYDY CytoDyn Inc
04/09/2020 8:03:50 PM
Dr. Sanjay Gupta is doing another t (2)
CYDY CytoDyn Inc
04/08/2020 1:45:15 PM
I am probably not the first from IH (10)
CYDY CytoDyn Inc
04/07/2020 8:45:38 AM
I think that the trial number could
CYDY CytoDyn Inc
04/07/2020 8:36:24 AM
After 50 patient data is reviewed, (4)
CYDY CytoDyn Inc
04/06/2020 8:17:06 PM
Question - on Wednesday afternoon (
CYDY CytoDyn Inc
04/06/2020 3:30:51 PM
NP and BP seemed so relaxed and con
CYDY CytoDyn Inc
04/06/2020 3:20:24 PM
I was just thinking about our phase
CYDY CytoDyn Inc
04/06/2020 10:49:31 AM
I am excited to hear NP clarificati (1)
CYDY CytoDyn Inc
04/06/2020 7:28:20 AM
IMO, I read the title of the PR as (2)
CYDY CytoDyn Inc
04/05/2020 8:40:36 PM
It is highly unlikely that there w
CYDY CytoDyn Inc
04/04/2020 10:37:42 AM
Come to think of it, adding a secon (1)
CYDY CytoDyn Inc
04/04/2020 10:32:13 AM
I think they were in the picture we (2)
CYDY CytoDyn Inc
04/04/2020 10:23:11 AM
Regardless of what NP did or did no (2)
CYDY CytoDyn Inc
04/04/2020 10:07:29 AM
So I don't believe that NP shared a
Go to page:
  • << First
  • < Previous
  • 5
  • 6
  • Next >

Recent Articles

  • Tesla's Model Y L: Are Fans Right to Be Concerned About Delays?
  • Join the Upcoming Investor Conference Webinar with KN
  • Tharimmune Experiences Significant Stock Surge Post Drug News
  • Metacon Reports Significant Revenue Growth in Recent Quarter
  • Navigating Market Shifts: Insights from Upcoming Events
  • Articulated Robots Set to Revolutionize Industries by 2032
  • NACON Showcases Exciting New Games at Gamescom 2025
  • Anoto Secures Bridge Loan to Propel INQ Smartpen Expansion
  • Insight into NB Private Equity Partners' Recent Share Buyback
  • OSB Group PLC's Significant Share Buyback Activity Announced
  • ICG Enterprise Trust Shares Buyback Details and Implications
  • Foresight Group Expands Its Share Buyback Initiative
  • Join KN's Investor Conference Webinar for Financial Insights
  • Novonesis Exhibits Robust Growth and Strategic Outlook for Future
  • Novonesis Sees Robust Growth and Strengthens Market Position
  • Novonesis Achieves Impressive 9% Organic Sales Growth
  • ROHM Unveils Groundbreaking Compact MOSFET for Fast Charging
  • Lowe's Positioning for Future Growth: A Valuable Investment
  • Novonesis Reports Strong Organic Growth and 2025 Outlook Adjustments
  • Geopolitical Tensions Shape Nvidia's Future in China Market
  • Nicox's NCX 470 Phase 3 Trial Showcases Efficacy in Glaucoma
  • Aker BP ASA Enhances Yggdrasil’s Potential with New Oil Find
  • Unveiling VISVISE: The Future of Game Art Design by Tencent
  • Nicox Showcases Promising Advances with NCX 470 in Glaucoma
  • Multitude Capital Oyj Reports Strong Growth in H1 2025
  • Icelandic Salmon Unveils Key Insights for Q2 and H1 Results 2025
  • Sampo plc's Remarkable Share Buyback: Insights and Impact
  • Endeavour Mining Successfully Executes Share Buyback Program
  • ALK's Q2 Growth Surges with 12% Revenue Increase
  • EDF’s Historic Bond Issuance: A Leap Towards Sustainable Energy
  • Gavin Newsom Responds to Beyond Inc.'s Store Strategy Reversal
  • Multitude Capital Releases Impressive H1 2025 Financials
  • Icelandic Salmon's Outlook for 2025: Key Insights and Analysis
  • ALK's Q2 Results Reflect Strong Growth and Positive Outlook
  • Kojamo's Financial Report Highlights: Growth and Outlook
  • Herantis Pharma Announces 1H 2025 Report with Key Developments
  • Systemair AB Reports First Quarter Results with Growth Insights
  • Aker BP ASA's Innovative Oil Discovery Boosts Industry Growth
  • GN Store Nord Reports Impressive Q2 2025 Financial Results
  • DNO ASA Reports Major Earnings Growth and Dividend Increase
  • Molecular Partners Welcomes Martin Steegmaier as New CSO
  • Vantage Drilling International's Upcoming Earnings Call Details
  • Kojamo plc Surges in Financial Performance in Mid-2025 Review
  • Kinepolis Cinemas Thriving with Blockbuster Success Insights
  • VGP Reports Strong Half-Year Performance with Record Growth
  • DNO ASA Announces Exciting Dividend Payment for Shareholders
  • Aegon's 2025 Mid-Year Results Showcase Positive Growth Trends
  • Molecular Partners Welcomes Martin Steegmaier as CSO for DARPin Innovation
  • Aegon's Half-Year Report Showcases Remarkable Financial Growth
  • Nordson Corp Sees 5% Surge in After-Hours Trading Driven by Q3 Results
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site